期刊文献+
共找到4,566篇文章
< 1 2 229 >
每页显示 20 50 100
Advancing laboratory animal science in the Philippines:PALAS initiatives and partnerships leading to Asia Laboratory Animal Day 2025
1
作者 Rodel Jonathan S.Vitor II John Sylvester B.Nas +8 位作者 Bryan John A.Magoling Frances C.Recuenco Sharon Yvette Angelina M.Villanueva Catherine T.Albano Delwin D.Capuyo Sebastian Jose David Ma.Danica Ines-Ramil Alisha Wehdnesday B.Reyes Cherry P.Fernandez-Colorado 《Animal Models and Experimental Medicine》 2025年第12期2184-2186,共3页
As the Philippines celebrated the 2nd Asia Laboratory Animal Day(ALAD)last November 29,2025,the Philippine Association for Laboratory Animal Sciences(PALAS)reflected on a year marked by growth,collaboration,and renewe... As the Philippines celebrated the 2nd Asia Laboratory Animal Day(ALAD)last November 29,2025,the Philippine Association for Laboratory Animal Sciences(PALAS)reflected on a year marked by growth,collaboration,and renewed commitment to ethical and scientific excellence in animal-based research.Throughout 2025,PALAS has continued to strengthen the laboratory animal science community by advancing education,capacity building,policy advocacy,and regional cooperation.These efforts underscore PALAS’vital role in shaping a culture of responsible animal research aligned with international standards. 展开更多
关键词 animal welfare and ethics laboratory animal practice laboratory animal science
在线阅读 下载PDF
Enhancing neural stem cell integration in the injured spinal cord through targeted PTEN modulation 被引量:1
2
作者 Simay Geniscan Hee Hwan Park +6 位作者 Hyung Soon Kim Seokjin Yoo Hyunmi Kim Byeong Seong Jang Dong Hoon Hwang Kevin K Park Byung Gon Kim 《Neural Regeneration Research》 2026年第4期1586-1594,共9页
Spinal cord injury results in permanent loss of neurological functions due to severance of neural networks.Transplantation of neural stem cells holds promise to repair disrupted connections.Yet,ensuring the survival a... Spinal cord injury results in permanent loss of neurological functions due to severance of neural networks.Transplantation of neural stem cells holds promise to repair disrupted connections.Yet,ensuring the survival and integration of neural stem cells into the host neural circuit remains a formidable challenge.Here,we investigated whether modifying the intrinsic properties of neural stem cells could enhance their integration post-transplantation.We focused on phosphatase and tensin homolog(PTEN),a well-characterized tumor suppressor known to critically regulate neuronal survival and axonal regeneration.By deleting Pten in mouse neural stem cells,we observed increased neurite outgrowth and enhanced resistance to neurotoxic environments in culture.Upon transplantation into injured spinal cords,Pten-deficient neural stem cells exhibited higher survival and more extensive rostrocaudal distribution.To examine the potential influence of partial PTEN suppression,rat neural stem cells were treated with short hairpin RNA targeting PTEN,and the PTEN knockdown resulted in significant improvements in neurite growth,survival,and neurosphere motility in vitro.Transplantation of sh PTEN-treated neural stem cells into the injured spinal cord also led to an increase in graft survival and migration to an extent similar to that of complete deletion.Moreover,PTEN suppression facilitated neurite elongation from NSC-derived neurons migrating from the lesion epicenter.These findings suggest that modifying intrinsic signaling pathways,such as PTEN,within neural stem cells could bolster their therapeutic efficacy,offering potential avenues for future regenerative strategies for spinal cord injury. 展开更多
关键词 graft axon growth graft survival neural stem cell PTEN regeneration spinal cord injury transplantation
暂未订购
Biomimetic Nanotechnology Integrating TargetedDelivery and Immune Regulation in Stroke Therapy
3
作者 LIU Yang 《生物化学与生物物理进展》 北大核心 2026年第3期515-515,共1页
Ischemic stroke therapy has long been dominated by strategies aimed at restoring cerebral blood flow. Yet, accumulating evidence suggests that neuronal survival and functional recovery depend not only on reperfusion, ... Ischemic stroke therapy has long been dominated by strategies aimed at restoring cerebral blood flow. Yet, accumulating evidence suggests that neuronal survival and functional recovery depend not only on reperfusion, but also on the resolution of postischemic immune dysregulation. This study(Chen et al., Prog Biochem Biophys, 2026, 53(3): 697-710. DOI:10.3724/j.pibb.2025.0541) a dvances this emerging paradigm by proposing a therapeutic strategy that integrates lesion-specific delivery with active modulation of the inflammatory microenvironment. 展开更多
关键词 neuronal survival active modulation o immune regulation ischemic stroke therapeutic strategy ischemic stroke therapy biomimetic nanotechnology restoring cerebral blood flow
原文传递
Engineered bacterial drugs in cancer and IBD therapy:challenges and future perspectives
4
作者 Ru-Ying Zhan Jin Hai Zheng 《Biomedical Engineering Communications》 2026年第3期1-3,共3页
Tumor immunotherapy has been recognized by Science as the most promising therapeutic approach for tumor eradication,with engineered bacteria emerging as a particularly promising modality.As a novel drug delivery platf... Tumor immunotherapy has been recognized by Science as the most promising therapeutic approach for tumor eradication,with engineered bacteria emerging as a particularly promising modality.As a novel drug delivery platform,the engineered bacterial therapeutics demonstrate exceptional targeting precision and favorable safety profiles.Through attenuation and programmable control strategies,these systems enable highly specific drug delivery,showing significant therapeutic potential in oncology and inflammatory bowel disease(IBD). 展开更多
关键词 drug delivery platformthe engineered bacterial therapeutics engineered bacteria tumor immunotherapy attenuation programmable control strategiesthese inflammatory bowel disease drug delivery platform
暂未订购
Proactively restore visual function:Directly targeting affected retinal neurons
5
作者 Ioannis Smyrnias Ngan Pan Bennett Au 《Neural Regeneration Research》 2026年第7期2960-2961,共2页
Our optic nerves are vulnerable to both traumatic and non-traumatic insults,rendering optic neuropathy a leading cause of permanent and irreversible visual impairment.Optic neuropathies can arise from hereditary[e.g.,... Our optic nerves are vulnerable to both traumatic and non-traumatic insults,rendering optic neuropathy a leading cause of permanent and irreversible visual impairment.Optic neuropathies can arise from hereditary[e.g.,dominant optic atrophy(DOA)and Leber hereditary optic neuropathy(LHON)],ischaemic(e.g.,anterior and posterior ischaemic optic neuropathy),inflammatory(e.g.,optic neuritis),toxic(e.g.,methanol,ethambutol)and nutritional(e.g.,vitamin B12 deficiency),or traumatic conditions.Amongst these,glaucomatous optic neuropathy represents the most prevalent form and constitutes the second leading cause of blindness worldwide,with approximately 10%of patients developing bilateral blindness.Currently,over 76 million people are affected by glaucoma globally-a number predicted to rise to 112 million by 2040.Current treatments primarily focus on lowering intraocular pressure(IOP)through topical medications and surgical interventions. 展开更多
关键词 leber hereditary optic neuropathy lhon ischaemic eganterior optic atrophy doa traumatic insults retinal neurons non traumatic insults optic neuropathy visual impairment optic nerves
暂未订购
Safety and oncologic outcomes of open versus minimally invasive distal pancreatectomy for resectable pancreatic body and tail cancer
6
作者 Hajime Imamura Tomohiko Adachi +5 位作者 Ayaka Kinoshita Takashi Hamada Hajime Matsushima Takanobu Hara Akihiko Soyama Susumu Eguchi 《Hepatobiliary & Pancreatic Diseases International》 2026年第1期83-90,共8页
Background:Minimally invasive distal pancreatectomy(MIDP)is increasingly being used,although its oncologic safety for pancreatic ductal adenocarcinoma(PDAC)remains controversial.In Japan,MIDP for PDAC has limited endo... Background:Minimally invasive distal pancreatectomy(MIDP)is increasingly being used,although its oncologic safety for pancreatic ductal adenocarcinoma(PDAC)remains controversial.In Japan,MIDP for PDAC has limited endorsement due to insufficient data.This study aimed to compare the perioperative and long-term outcomes of open distal pancreatectomy(ODP)and MIDP for PDAC.Methods:We retrospectively analyzed patients with resectable pancreatic body and tail cancer treated with ODP or MIDP(laparoscopic or robotic)between January 2007 and July 2022.The surgical procedures(ODP and MIDP)were compared and the patient characteristics,perioperative outcomes,and long-term outcomes were analyzed.We also compared the outcomes of patients with neoadjuvant chemotherapy(NAC)and without NAC.Results:A total of 72 distal pancreatectomies were performed(37 ODPs and 35 MIDPs).In the upfront group,MIDP resulted in significantly less blood loss than ODP(P<0.01),despite similar operative time.There was no statistically significant difference in the 2-year recurrence-free survival(RFS)rates between ODP and MIDP(39.7%vs.57.8%,P=0.60)or in the overall survival(OS)rates(66.7%vs.74.1%,P=0.43).Similarly,in the NAC group,MIDP resulted in significantly less blood loss than ODP(P=0.01);ODP and MIDP had similar 2-year RFS rates(41.7%and 60.0%,P=0.75)and OS rates(50.0%and 70.0%,P=0.36).The interval from surgery to adjuvant chemotherapy initiation did not significantly differ between the ODP and MIDP subgroups in both the upfront group(P=0.13)and the NAC group(P=0.14).The incidence of recurrence was 64.8%for ODP and 42.8%for MIDP(P=0.06).Both procedures showed similar distributions of local and distant recurrence.Conclusions:MIDP caused less blood loss and had similar oncologic safety compared with ODP.MIDP could become a feasible,minimally invasive option with sufficient oncologic safety for pancreatic body and tail cancers. 展开更多
关键词 Pancreatic body cancer Pancreatic tail cancer Minimally invasive pancreatectomy Laparoscopic distal pancreatectomy Robotic distal pancreatectomy Oncologic safety
暂未订购
Partial-EMT in oral squamous cell carcinoma:molecular circuitry and clinical translation
7
作者 Chunhua Wang Motoharu Sarubo +1 位作者 Siqi Chen Yasusei Kudo 《International Journal of Oral Science》 2026年第1期18-32,共15页
Oral squamous cell carcinoma(OSCC)is a prevalent malignancy with high morbidity and mortality.Globally,about 400000 people are affected,often with a poor quality of life.Its high mortality is mainly due to its aggress... Oral squamous cell carcinoma(OSCC)is a prevalent malignancy with high morbidity and mortality.Globally,about 400000 people are affected,often with a poor quality of life.Its high mortality is mainly due to its aggressive growth and tendency to spread.Epithelial-mesenchymal transition(EMT)is a central regulatory hub driving tumor cell migration and invasion by enabling changes in cell characteristics.During EMT,epithelial cells gradually take on mesenchymal traits,gaining mobility and spreading mo re easily.Recent multi-omics studies show that many cancer cells exist in a hybrid or partial-EMT state,which lies between the full epithelial and mesenchymal forms.Cells in this state are especially invasive and metastatic,with high plasticity that promotes tumor progression.This review summarizes the role of partial-EMT in OSCC,with a focus on how it alters the tumor microenvironment(TME),promotes invasion and metastasis,and influences cancer stem cells(CSCs).We also highlight the link between partial-EMT and treatment resistance in OSCC.Based on these insights,we discuss therapeutic strategies targeting partial-EMT to improve outcomes.Targeting partial-EMT may offer promising strategies to enhance treatment effectiveness and improve patient survival and quality of life. 展开更多
关键词 cancer stem cells partial Epithelial mesenchymal transition oral squamous cell carcinoma emtepithelial cells invasion metastasis treatment resistance therapeutic strategies oral squamous cell carcinoma oscc
暂未订购
Opportunities and challenges of artificial intelligence-assisted endoscopy and high-quality data for esophageal squamous cell carcinoma
8
作者 Ken Kurisaki Shinichiro Kobayashi +6 位作者 Taro Akashi Yasuhiko Nakao Masayuki Fukumoto Kaito Tasaki Tomohiko Adachi Susumu Eguchi Kengo Kanetaka 《World Journal of Gastrointestinal Oncology》 2026年第1期61-74,共14页
This review comprehensively summarized the potential of artificial intelligence(AI)in the management of esophageal cancer.It highlighted the significance of AI-assisted endoscopy in Japan where endoscopy is central to... This review comprehensively summarized the potential of artificial intelligence(AI)in the management of esophageal cancer.It highlighted the significance of AI-assisted endoscopy in Japan where endoscopy is central to both screening and diagnosis.For the clinical adaptation of AI,several challenges remain for its effective translation.The establishment of high-quality clinical databases,such as the National Clinical Database and Japan Endoscopy Database in Japan,which covers almost all cases of esophageal cancer,is essential for validating multimodal AI models.This requires rigorous external validation using diverse datasets,including those from different endoscope manufacturers and image qualities.Furthermore,endoscopists’skills significantly affect diagnostic accuracy,suggesting that AI should serve as a supportive tool rather than a replacement.Addressing these challenges,along with country-specific legal and ethical considerations,will facilitate the successful integration of multimodal AI into the management of esophageal cancer,particularly in endoscopic diagnosis,and contribute to improved patient outcomes.Although this review focused on Japan as a case study,the challenges and solutions described are broadly applicable to other high-incidence regions. 展开更多
关键词 Artificial intelligence Esophageal cancer ENDOSCOPY Deep learning National database Clinical translation Multimodal artificial intelligence
暂未订购
Mechanisms and Therapeutic Strategies for HCV/HBV-Associated B-Cell Non-Hodgkin’s Lymphomas:A Viewpoint
9
作者 Guido Carloni Monica Rinaldi 《Oncology Research》 2026年第3期734-752,共19页
Hepatitis C virus(HCV)and hepatitis B virus(HBV)infections are increasingly recognized as significant etiological factors in the pathogenesis of B-cell non-Hodgkin’s lymphomas(B-NHLs).Epidemiological and molecular st... Hepatitis C virus(HCV)and hepatitis B virus(HBV)infections are increasingly recognized as significant etiological factors in the pathogenesis of B-cell non-Hodgkin’s lymphomas(B-NHLs).Epidemiological and molecular studies have demonstrated a consistent association between chronic viral infection and B-NHLs.Multiple pathogenic mechanisms have been implicated in lymphomagenesis,both direct and indirect,including chronic antigenic stimulation,direct infection of B cells,and viral protein-mediated oncogenic signaling,It is likely that a combination of several pathogenic conditions is required to eventually lead to the development of lymphoma.The prevalence of B-cell lymphomas among individuals with chronic HCV or HBV infection presents a complex pathogenetic scenario,given the tumor heterogeneity and variable clinical behavior,and poses therapeutic challenges,due to the partial efficacy of current treatment options.The advent of direct-acting antivirals(DAAs)for HCV and high-genetic barrier nucleos(t)ide analogues(NAs)for HBV has improved patient outcomes.In indolent HCV-associated B-NHLs,antiviral therapy with DAAs alone often achieves sustained virologic response and may lead to lymphoma regression.Conversely,aggressive subtypes like diffuse large B-cell lymphomas require combination treatment with immunochemotherapy.In the setting of HBV-associated lymphomas,antiviral prophylaxis with potent NAs(e.g.,entecavir or tenofovir)is essential to prevent HBV reactivation during rituximab-containing chemotherapy regimen.The integration of antiviral and anticancer therapies has been shown to enhance survival outcomes while mitigating hepatic toxicity.A comprehensive understanding of the biological interplay between chronic viral infection and B-cell transformation is critical for optimizing diagnostic and therapeutic strategies.Aim of this viewpoint is to provide evidence that early viral detection and prompt management remain the most effective strategies to improve survival rates and to reduce treatment-related morbidity in these patients. 展开更多
关键词 B-cell non-Hodgkin’s lymphomas(B-NHLs) hepatitis C virus(HCV) hepatitis B virus(HBV) chronic infection diffuse large B-cell lymphomas(DLBCL)
暂未订购
Dysregulated insulin signaling and inflammation contribute to the pathogenesis of Alzheimer’s disease:From animal models to human cells
10
作者 Marcus Elo Rytter Cecilie Amalie Brøgger Svane +1 位作者 Joachim Størling Wenqiang Chen 《Neural Regeneration Research》 2026年第3期1126-1127,共2页
The shared links between Alzheimer’s disease and type 2 diabetes mellitus:Alzheimer’s disease(AD)and type 2 diabetes mellitus(T2DM)are two prevalent conditions that come with substantial daily struggles.Emerging evi... The shared links between Alzheimer’s disease and type 2 diabetes mellitus:Alzheimer’s disease(AD)and type 2 diabetes mellitus(T2DM)are two prevalent conditions that come with substantial daily struggles.Emerging evidence highlights that these diseases share similar pathophysiological features,including insulin resistance and chronic inflammation,which contribute to their rapid progression(Chen et al.,2022).Insulin resistance,a hallmark of T2DM,has been suggested to exacerbate neurodegeneration in AD.Similarly,chronic low-grade inflammation in T2DM parallels with neuroinflammation,which is observed in AD,suggesting overlapping pathophysiological mechanisms in T2DM and AD. 展开更多
关键词 alzheimer s disease chronic inflammationwhich type diabetes mellitus alzheimer s disease ad INFLAMMATION exacerbate neurodegeneration Alzheimers disease insulin resistance type diabetes mellitus t dm
暂未订购
Whole genome analysis of a Non-O1,Non-O139 Vibrio cholerae isolate from a bacteremia case in Ho Chi Minh City
11
作者 Tuan-Loc Le Ngoc-Lan Nguyen +1 位作者 Duc-Khai Luong Hieu Vu-Quang 《Asian Pacific Journal of Tropical Medicine》 2026年第2期94-96,I0062-I0065,共7页
Non-O1/non-O139 Vibrio(V.)cholerae(NOVC)has emerged as a potential pathogen in patients with compromised health conditions[1].We report the whole genome sequencing(WGS)of a rare NOVC sepsis isolate(GenBank Accession:G... Non-O1/non-O139 Vibrio(V.)cholerae(NOVC)has emerged as a potential pathogen in patients with compromised health conditions[1].We report the whole genome sequencing(WGS)of a rare NOVC sepsis isolate(GenBank Accession:GCF_051906115.1)from an 89-year-old male admitted to the Intensive Care Unit(ICU)with septic shock(lactate 6.61 mmol/L)digestive illness. 展开更多
关键词 septic shock intensive care BACTEREMIA intensive care unit whole genome sequencing wgs Whole genome analysis non O non O Vibrio cholerae sepsis
暂未订购
The mechanical loading environment associated with eccentric exercise is one of the key stimuli to trigger sarcomerogenesis:It’s a stretch to say eccentric exercise does not promote serial sarcomerogenesis
12
作者 Geoffrey A.Power Martino V.Franchi Avery Hinks 《Journal of Sport and Health Science》 2026年第4期312-314,共3页
The addition of sarcomeres in series(sarcomerogenesis)in skeletal muscle has increasingly fascinated exercise scientists in recent years due to its potential to positively impact performance.1,2 In their new review ar... The addition of sarcomeres in series(sarcomerogenesis)in skeletal muscle has increasingly fascinated exercise scientists in recent years due to its potential to positively impact performance.1,2 In their new review article,Triggering sarcomerogenesis:Examining key stimuli and the role attributed to eccentric training—Historical,systematic,and meta-analytic review,Blazevich et al.3 provide a commendable overview of the history behind this area of research from the 1600s to present. 展开更多
关键词 eccentric exercise performance review article eccentric training historicalsystematicand sarcomerogenesis skeletal muscle historical overview exercise scientists
在线阅读 下载PDF
Food-derived extracellular vesicles:isolation,characteristics,bioactivities,applications as targeted delivery carriers and adverse consequences
13
作者 Saichao Wei Kehai Liu 《Food Science and Human Wellness》 2026年第2期489-507,共19页
Delivery carriers serve as a highly efficient approach for precision nutrition and medicine;however,artificial delivery carriers are prone to triggering the immune response and have the disadvantages of poor stability... Delivery carriers serve as a highly efficient approach for precision nutrition and medicine;however,artificial delivery carriers are prone to triggering the immune response and have the disadvantages of poor stability and low bioavailability.Extracellular vesicles(EVs),nucleus-free biological particles composed of phospholipid bilayers secreted by living cells,are a new generation of targeted delivery carriers.In recent years,an increasing number of species have been reported to contain EVs.Among them,food-derived extracellular vesicles(FDEVs)show outstanding comprehensive properties.FDEVs are considered to have great application potential due to their wide range of sources,high yields,absence of human pathogenic pathogens,and ethical concerns.In this review,the preparation,nomenclature,physicochemical characteristics,and preservation methods of FDEVs are discussed,as well as their potential protein markers,bioactivities,and applications as novel targeted delivery carriers of FDEVs from animals,plants,and microorganisms.We also summarized the adverse consequences of FDEVs in current studies,and put forward the problems and challenges in the process of FDEVs research and commercialization.In short,the importance of FDEVs has been highlighted,and FDEVs have good application prospects as a new class of targeted delivery carriers.The current problems should be paid attention to and actively solved. 展开更多
关键词 Food-derived extracellular vesicles BIOACTIVITIES Targeted delivery carriers Adverse consequences CHALLENGES
在线阅读 下载PDF
Ferroptosis as a Translational Axis in Small Cell Lung Cancer:A Systematic Review of Redox Pathways and Precision Oncology Prospects
14
作者 Donatella Coradduzza Anna La Salvia +1 位作者 Giuseppe Fanciulli Maria Rosaria De Miglio 《Oncology Research》 2026年第4期122-157,共36页
Background:An increasing number of studies have shown that ferroptosis is related to the initiation and development of small cell lung cancer(SCLC).The systematic review aimed to summarize the characteristics of ferro... Background:An increasing number of studies have shown that ferroptosis is related to the initiation and development of small cell lung cancer(SCLC).The systematic review aimed to summarize the characteristics of ferroptosis from its pathogenetic role to translational therapeutic implications in SCLC.Methods:This systematic review,registered in PROSPERO(CRD420251090058),followed PRISMA 2020 guidelines.Comprehensive research of PubMed,Scopus,and Web of Science was performed for studies published between January 2010 and July 2025 investigating ferroptosis mechanisms,genetic or pharmacological modulation,or molecular profiling in SCLC.Two reviewers independently performed data extraction and quality assessment.Results:Nineteen preclinical studies met the inclusion criteria.Key regulators included solute carrier family 7 member 11(SLC7A11),glutathione peroxidase 4(GPX4),ferroptosis suppressor protein 1(FSP1),and acyl-CoA synthetase long chain family member 4(ACSL4).The molecular subtypes of SCLC,achaete-scute homolog 1(ASCL1),neuronal differentiation 1(NEUROD1),POU class 2 homeobox 3(POU2F3),and Yes1 associated transcriptional regulator(YAP1)exhibit differential ferroptosis gene expressions,influencing therapeutic responsiveness.Non-neuroendocrine subtypes are more ferroptosis-prone,whereas neuroendocrine variants display enhanced antioxidant defenses.Ferroptosis induction also promotes immune activation through stimulator of interferon genes(STING)-mediated CD8+T-cell recruitment.Conclusions:Ferroptosis constitutes a promising therapeutic axis in SCLC.Integrating ferroptosis biomarkers into molecular stratification frameworks could refine patient selection and support precision oncology strategies,warranting further translational and clinical validation. 展开更多
关键词 Small cell lung cancer ferroptosis lipid peroxidation glutathione peroxidase 4 solute carrier family 7 member 11 molecular subtypes IMMUNOTHERAPY oxidative stress regulated cell death translational oncology systematic review
暂未订购
Adipose tissue-brain crosstalk in comorbid obesity and traumatic brain injury:Insights into mechanisms
15
作者 Susan C.Burke Bogdan A.Stoica Rebecca J.Henry 《Neural Regeneration Research》 2026年第5期1989-1990,共2页
Obese individuals who subsequently sustain a traumatic brain injury(TBI)exhibit worsened outcomes including longer periods of rehabilitation(Eagle et al.,2023).In obese individuals,prolonged symptomology is associated... Obese individuals who subsequently sustain a traumatic brain injury(TBI)exhibit worsened outcomes including longer periods of rehabilitation(Eagle et al.,2023).In obese individuals,prolonged symptomology is associated with increased levels of circulato ry pro-inflammatory marke rs up to 1 year postTBI(Eagle et al.,2023). 展开更多
关键词 pro inflammatory markers comorbid obesity adipose tissue rehabilitation outcomes traumatic brain injury tbi exhibit traumatic brain injury brain crosstalk
暂未订购
Reevaluating the role of skeletal muscle in amyotrophic lateral sclerosis pathogenesis:Insights from muscle-derived factors
16
作者 Pablo Martinez Brigitte van Zundert Fernando J.Bustos 《Neural Regeneration Research》 2026年第7期2944-2945,共2页
Amyotrophic lateral sclerosis(ALS)is a progressive neurodegenerative disease marked by motor neuron(MN)degeneration,neuromuscular junction disruption,and muscle atrophy,ultimately leading to paralysis and death.Despit... Amyotrophic lateral sclerosis(ALS)is a progressive neurodegenerative disease marked by motor neuron(MN)degeneration,neuromuscular junction disruption,and muscle atrophy,ultimately leading to paralysis and death.Despite extensive research,no effective treatment exists,highlighting the need to elucidate mechanisms driving ALS pathogenesis.About 90%of ALS cases are sporadic ALS and lack a clear genetic cause;the remaining 10%are familial ALS,associated with mutations in over 25 genes.The most common mutations are in superoxide dismutase 1(SOD1)and C9ORF72,with rarer variants in FUS,TARDBP,TBK1,and VCP. 展开更多
关键词 amyotrophic lateral sclerosis als neurodegenerative disease elucidate mechanisms neuromuscular junction amyotrophic lateral sclerosis motor neuron muscle atrophyultimately junction disruptionand
暂未订购
BAG3 in traumatic brain injury:A cell-type-specific modulator of tau hyperphosphorylation
17
作者 Nicholas Sweeney Tae Yeon Kim Hongjun Fu 《Neural Regeneration Research》 2026年第6期2343-2344,共2页
BCL2-associated anthanogene 3 facilitates the clearance of tau protein aggregates:BCL2-associated anthanogene 3(BAG3)is a ubiquitously expressed and highly conserved multi-functional co-chaperone protein involved in m... BCL2-associated anthanogene 3 facilitates the clearance of tau protein aggregates:BCL2-associated anthanogene 3(BAG3)is a ubiquitously expressed and highly conserved multi-functional co-chaperone protein involved in many biological processes that supports cellular homeostasis,including the inhibition of apoptosis by preventing mitochondrial BAX localization(Lin et al.,2022)and the promotion of the degradation of hyperphosphorylated tau aggregates by its interactions with SQSTM1(p62)(Hamano and Mutoh,2022). 展开更多
关键词 inhibition apoptosis tau hyperphosphorylation traumatic brain injury cellular homeostasisincluding preventing mitochondrial bax localization lin BAG p biological processes
暂未订购
Recent Advances in Radiopharmaceuticals for Cancer Diagnosis and Therapy
18
作者 Ye Ri Han Sang Bong Lee 《Oncology Research》 2026年第4期189-210,共22页
Radiopharmaceuticals deliver diagnostic or therapeutic radionuclides to disease sites with molecular precision.Over the past five years,clinical adoption has accelerated,led by U.S.Food and Drug Administration approva... Radiopharmaceuticals deliver diagnostic or therapeutic radionuclides to disease sites with molecular precision.Over the past five years,clinical adoption has accelerated,led by U.S.Food and Drug Administration approvals of 177Lu-DOTA-TATE and 177Lu-PSMA-617 and their complementary Positron Emission Tomography agents(68Ga-DOTA-TATE,68Ga-PSMA-11),which have established radiotheranostics as a pillar of oncology care.The new generation of agents couples optimized radionuclides(β-,α,and Auger emitters)to antibodies,peptides,and small-molecule vectors that improve tumor uptake,residence time,and clearance profiles,thereby enhancing efficacy and safety.Beyond neuroendocrine tumors and prostate cancer,radiotheranostic strategies are advancing for diverse malignancies by exploiting tumor-specific antigens,overexpressed receptors,and intracellular targets.Notably,α-emitters such as 225Ac and 211At—owing to high linear energy transfer and short path length—show potent cytotoxicity with limited off-target injury,while emergingβ/Auger emitters like 161Tb may surpass 177Lu in microdosimetric effectiveness.Concurrent innovations in patient selection and response prediction leverage diagnostic radiopharmaceuticals for image-guided stratification,individualized dosimetry,and adaptive treatment planning,supporting the broader paradigm of precision medicine.Although oncology remains the primary focus,applications are expanding to neurodegeneration,cardiovascular disease,and inflammatory conditions.This review synthesizes technological and clinical progress from 2021-2025,spanning FDA-approved and late-stage investigational agents;mechanisms of radiopharmaceutical-induced cell death;dosimetry methodologies;trial landscapes for expanding indications;and translational challenges,including supply chains,chelation chemistry,and toxicity management.Accordingly,this review focuses on the latest radiopharmaceutical diagnostic and therapeutic technologies,integrating advances in radionuclide platforms,targeting vectors,dosimetry,and clinical trial data from 2021-2025 to guide future development and clinical implementation of precision radiotheranostics. 展开更多
关键词 Radiotheranostics radioligand therapy alpha emitters terbium-161 prostate-specific membrane antigen somatostatin receptor patient stratification DOSIMETRY precision oncology
暂未订购
Pan-biological characteristics of ataxin-2 protein
19
作者 AndréConceição Clévio Nóbrega 《Neural Regeneration Research》 2026年第7期2952-2953,共2页
Ataxin-2 is a 140 kDa cytoplasmic multifunctional protein that plays fundamental roles in diverse cellular mechanisms(Costa et al.,2024).Although widely studied in the context of the neurodegenerative diseases spinoce... Ataxin-2 is a 140 kDa cytoplasmic multifunctional protein that plays fundamental roles in diverse cellular mechanisms(Costa et al.,2024).Although widely studied in the context of the neurodegenerative diseases spinocerebellar ataxia type 2(SCA2)and amyotrophic lateral sclerosis(ALS),ataxin-2 functions span far beyond its pathogenic properties in the disease context(Figure 1).In fact,it has a wide range of biological functions that include RNA metabolism,translation regulation,stress response,endocytosis,calcium signaling,and the control of circadian rhythm.In this perspective,we highlight the main roles of ataxin-2 protein,which are described in detail in Costa et al.(2024). 展开更多
关键词 rna metabolismtranslation neurodegenerative diseases ataxin multifunctional protein amyotrophic lateral sclerosis als ataxin spinocerebellar ataxia type sca PROTEIN cellular mechanisms costa
在线阅读 下载PDF
Extra-pineal melatonin in perisynaptic Schwann cell–muscle fiber cross talk at the regenerating neuromuscular junction
20
作者 Samuele Negro Cesare Montecucco Michela Rigoni 《Neural Regeneration Research》 2026年第1期300-301,共2页
The neuromuscular junction and its proregenerative niche:The mammalian peripheral nervous system,unlike the central nervous system,has preserved throughout evolution the ability to regenerate and fully restore functio... The neuromuscular junction and its proregenerative niche:The mammalian peripheral nervous system,unlike the central nervous system,has preserved throughout evolution the ability to regenerate and fully restore function.Key factors for effective nerve regeneration include a supportive neuronal environment and a coordinated tissue response(Brosius Lutz and Barres,2014). 展开更多
关键词 FUNCTION SYSTEM COORDINATED
在线阅读 下载PDF
上一页 1 2 229 下一页 到第
使用帮助 返回顶部